These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. An 11-year retrospective study: clinicopathological and survival analysis of gastro-entero-pancreatic neuroendocrine neoplasm. Liu H, Xie R, Zhao Z, Xu D, Yang K, Ding M, Tan D, Liao W, Han X, Zhang J, Shen D, Yuan J, Xu Z, Fei J. Medicine (Baltimore); 2020 Aug 14; 99(33):e21682. PubMed ID: 32872039 [Abstract] [Full Text] [Related]
7. Clinicopathologic characteristics and prognosis of gastroenteropancreatic neuroendocrine neoplasms: a multicenter study in South China. Fang C, Wang W, Zhang Y, Feng X, Sun J, Zeng Y, Chen Y, Li Y, Chen M, Zhou Z, Chen J. Chin J Cancer; 2017 Jun 21; 36(1):51. PubMed ID: 28637502 [Abstract] [Full Text] [Related]
8. Surgery of the primary tumour in 201 patients with high-grade gastroenteropancreatic neuroendocrine and mixed neuroendocrine-non-neuroendocrine neoplasms. Pommergaard HC, Nielsen K, Sorbye H, Federspiel B, Tabaksblat EM, Vestermark LW, Janson ET, Hansen CP, Ladekarl M, Garresori H, Hjortland GO, Sundlöv A, Galleberg R, Knigge P, Kjaer A, Langer SW, Knigge U. J Neuroendocrinol; 2021 May 21; 33(5):e12967. PubMed ID: 33769624 [Abstract] [Full Text] [Related]
13. The overriding role of surgery and tumor grade for long-term survival in patients with gastroenteropancreatic neuroendocrine neoplasms: A population-based cohort study. Søreide JA, Kvaløy JT, Lea D, Sandvik OM, Al-Saiddi M, Haslerud TM, Garresori H, Karlsen LN, Gudlaugsson E, Søreide K. Cancer Rep (Hoboken); 2022 Feb 09; 5(2):e1462. PubMed ID: 34105314 [Abstract] [Full Text] [Related]
16. Natural history of gastro-entero-pancreatic and thoracic neuroendocrine tumors. Data from a large prospective and retrospective Italian epidemiological study: the NET management study. Faggiano A, Ferolla P, Grimaldi F, Campana D, Manzoni M, Davì MV, Bianchi A, Valcavi R, Papini E, Giuffrida D, Ferone D, Fanciulli G, Arnaldi G, Franchi GM, Francia G, Fasola G, Crinò L, Pontecorvi A, Tomassetti P, Colao A. J Endocrinol Invest; 2012 Oct 09; 35(9):817-23. PubMed ID: 22080849 [Abstract] [Full Text] [Related]
17. A nomogram incorporating treatment data for predicting overall survival in gastroenteropancreatic neuroendocrine tumors: a population-based cohort study. Wu Z, Shang G, Zhang K, Wang W, Fan M, Lin R. Int J Surg; 2024 Apr 01; 110(4):2178-2186. PubMed ID: 38241384 [Abstract] [Full Text] [Related]
19. The Risk of Second Primary Colorectal Adenocarcinomas Is Not Increased among Patients with Gastroenteropancreatic Neuroendocrine Neoplasms: A Nationwide Population-Based Study. Stemann Lau T, Dam G, Jepsen P, Grønbæk H, Krogh K, Gregersen T. Neuroendocrinology; 2018 Apr 01; 107(3):280-283. PubMed ID: 30092588 [Abstract] [Full Text] [Related]